CAMBRIAN MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: M82026 | OSWESTRY, SY11 1GA
Showing results 101-150 of 716
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Pravastatin sodium | 686 | 19.6K | £897 | +111.2% ▲ |
| Insulin glargine | 680 | 3,258 | £27.9K | +139.5% ▲ |
| Flucloxacillin sodium | 677 | 39.2K | £2.1K | +50.6% ▲ |
| Mebeverine hydrochloride | 674 | 57.7K | £4.7K | +117.1% ▲ |
| Perindopril erbumine | 659 | 19.5K | £1.7K | +24.1% ▲ |
| Edoxaban | 654 | 16.3K | £27.1K | -6.6% ▼ |
| Levetiracetam | 645 | 61.8K | £5.9K | +40.9% ▲ |
| Desogestrel | 641 | 82.0K | £2.3K | +61.7% ▲ |
| Betamethasone valerate | 639 | 48.4K | £5.9K | +66.0% ▲ |
| 639 | 7,145 | £1.5K | +205.7% ▲ | |
| Hydrocortisone | 630 | 19.5K | £3.5K | +40.5% ▲ |
| Carbamazepine | 627 | 60.4K | £4.5K | +111.3% ▲ |
| Felodipine | 616 | 18.4K | £2.3K | +3.7% ▲ |
| Betahistine hydrochloride | 612 | 51.0K | £2.0K | +156.3% ▲ |
| Alogliptin | 604 | 17.2K | £15.5K | +138.2% ▲ |
| Umeclidinium bromide/vilanterol | 602 | 605 | £18.7K | +208.7% ▲ |
| Nifedipine | 601 | 23.7K | £3.8K | +220.7% ▲ |
| Sumatriptan succinate | 599 | 4,948 | £2.3K | +69.1% ▲ |
| Trimethoprim | 590 | 18.4K | £1.0K | +188.7% ▲ |
| Quinine sulfate | 570 | 16.2K | £2.5K | +96.9% ▲ |
| Gliclazide | 561 | 33.3K | £1.2K | -34.1% ▼ |
| Sodium valproate | 556 | 115.1K | £9.6K | +74.8% ▲ |
| 552 | 577 | £2.8K | +133.7% ▲ | |
| Hydroxocobalamin | 549 | 883 | £1.9K | +14.1% ▲ |
| Ibuprofen | 544 | 59.7K | £2.9K | +6.9% ▲ |
| Thiamine hydrochloride | 525 | 26.3K | £716 | -0.4% vs avg |
| Tiotropium bromide | 515 | 3,686 | £11.7K | +69.4% ▲ |
| Timolol and bimatoprost | 494 | 7,127 | £7.3K | +225.5% ▲ |
| Estradiol | 482 | 11.9K | £6.5K | +78.7% ▲ |
| 482 | 62.9K | £1.8K | +74.3% ▲ | |
| 461 | 465 | £20.6K | +48.4% ▲ | |
| Methotrexate | 448 | 10.3K | £617 | +37.6% ▲ |
| Valsartan | 447 | 14.3K | £3.4K | +658.9% ▲ |
| Loperamide hydrochloride | 445 | 23.7K | £1.0K | +91.1% ▲ |
| Fluticasone propionate (Inhalation) | 444 | 464 | £12.0K | +14.7% ▲ |
| Lorazepam | 440 | 15.1K | £5.4K | +208.7% ▲ |
| Methylphenidate hydrochloride | 432 | 14.4K | £10.3K | +67.3% ▲ |
| Prochlorperazine maleate | 432 | 18.0K | £1.4K | +113.7% ▲ |
| 429 | 14.2K | £5.8K | +454.8% ▲ | |
| 424 | 57.2K | £2.2K | -10.6% ▼ | |
| Ready to serve 1.5 kcal/ml milkshake (0913011) | 422 | 3.5M | £24.8K | +196.9% ▲ |
| Baclofen | 418 | 62.8K | £1.1K | +108.7% ▲ |
| Moxonidine | 407 | 18.1K | £2.4K | +631.1% ▲ |
| Mesalazine (Systemic) | 404 | 43.8K | £16.3K | +68.7% ▲ |
| Semaglutide | 389 | 10.2K | £30.3K | +61.6% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 386 | 41.0K | £3.3K | +70.8% ▲ |
| Estradiol with progestogen | 385 | 14.6K | £11.0K | +13.0% ▲ |
| Linagliptin | 382 | 9,336 | £10.5K | -6.7% ▼ |
| Nefopam hydrochloride | 379 | 37.6K | £1.6K | +235.1% ▲ |
| Olanzapine | 377 | 8,871 | £993 | +1.8% vs avg |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.